DIFFUSION PHARMACEUTICALS INC. (DFFN) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition
On November 14, 2016, Diffusion Pharmaceuticals Inc. (the
Company) issued a press release announcing its financial results
for its third quarter ended September 30, 2016. A copy of that
press release is attached as Exhibit99.1 to this report and
incorporated herein by reference.
The information in this report (including Exhibit99.1) is being
furnished to Item 2.02 and shall not be deemed to be filed for
purposes of Section18 of the Securities Exchange Act of 1934, as
amended (the Exchange Act), or otherwise subject to the
liabilities of that section, nor shall it be deemed to be
incorporated by reference in any filing under the Securities Act
of 1933, as amended, or the Exchange Act.
Item9.01 Financial Statements and Exhibits
(d)Exhibits.
|
ExhibitNumber |
|
Description |
|
99.1 |
Press release dated November 14, 2016, announcing financial |
About DIFFUSION PHARMACEUTICALS INC. (DFFN)
